Bronchiolitis Obliterans Syndrome and Treatment Strategies
Author Information
Author(s): Hayes Don Jr
Primary Institution: The Ohio State University
Hypothesis
What are the therapeutic strategies for managing bronchiolitis obliterans syndrome (BOS) in lung transplant recipients?
Conclusion
Lung retransplantation remains a controversial but improving option for patients with bronchiolitis obliterans syndrome.
Supporting Evidence
- BOS is the leading cause of death beyond the first year post lung transplantation.
- Survival rates for lung retransplantation have improved over the past decade.
- Routine screening for BOS is crucial for early intervention.
Takeaway
Bronchiolitis obliterans syndrome is a serious condition that can occur after lung transplants, and while treatments exist, they mainly help slow down the problem rather than fix it.
Methodology
This manuscript reviews bronchiolitis obliterans syndrome and current therapeutic strategies, including outcomes for lung retransplantation.
Limitations
The therapies available for BOS are limited and primarily serve to slow the decline in pulmonary function.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website